Gilead Sciences, Inc. (ETR:GIS)
Germany · Delayed Price · Currency is EUR 106.54
-0.24 (-0.22%)
Nov 6, 2025, 5:35 PM CET
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €132.85 billion as of November 6, 2025. Its market cap has increased by 30.88% in one year.
Market Cap
132.85B
Enterprise Value
146.22B
Revenue
24.79B
Ranking
n/a
PE Ratio
19.22
Stock Price
€106.54
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 132.85B, an increase of 68,209.85%. That is a compound annual growth rate of 21.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 132.85B | 19.48% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | 59.70B | -18.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 50.07B |
| Merck KGaA | 48.04B |
| Fresenius SE & Co. KGaA | 27.06B |
| Bayer Aktiengesellschaft | 25.96B |
| Sartorius Aktiengesellschaft | 13.99B |
| Fresenius Medical Care AG | 12.09B |
| Fielmann Group AG | 3.90B |
| Carl Zeiss Meditec AG | 3.75B |